Raffles Medical Group Ltd (SGX:BSL)
Singapore · Delayed Price · Currency is SGD | Market Cap | 1.95B +25.7% |
| Revenue (ttm) | 765.30M +1.7% |
| Net Income | 70.57M +13.4% |
| EPS | 0.04 +14.1% |
| Shares Out | 1.84B |
| PE Ratio | 27.82 |
| Forward PE | 26.97 |
| Dividend | 0.03 (2.83%) |
| Ex-Dividend Date | May 12, 2026 |
| Volume | 3,325,400 |
| Average Volume | 2,355,460 |
| Open | 1.040 |
| Previous Close | 1.040 |
| Day's Range | 1.040 - 1.060 |
| 52-Week Range | 0.900 - 1.090 |
| Beta | 0.18 |
| RSI | 63.06 |
| Earnings Date | Feb 23, 2026 |
About Raffles Medical Group
Raffles Medical Group Ltd provides private healthcare services in Singapore, Greater China, Vietnam, Cambodia, and Japan. It operates through four segments: Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services. The company operates Raffles Hospital that offers 24-hour acute and critical care; ambulance services and mobile medical calls to home, hotels, worksites, and onboard ships; and triage, emergency consultation, and inpatient ward admission services. Its hospital also provides various services, including covi... [Read more]
Financial Performance
In 2025, Raffles Medical Group's revenue was 765.30 million, an increase of 1.71% compared to the previous year's 752.41 million. Earnings were 70.57 million, an increase of 13.38%.
Financial StatementsNews
Raffles Medical Group: China business still grew in 2024
Loo Choon Yong, Executive Chairman of Raffles Medical Group, talks about business in China and the country's efforts to liberalize its healthcare market.